LEERINK PARTNERS GLOBAL HEALTHCARE CONFERENCE

Lilly To Participate in Leerink Partners Global Healthcare Conference

Retrieved on:

Thursday, February 14, 2019

Leerink Partners, Eli Lilly and Company, Eli Lilly, LLY, Health, Lilly, Industries, Economy of the United States

INDIANAPOLIS, Feb. 14, 2019 /PRNewswire/ --Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019.

Key Points:

INDIANAPOLIS, Feb. 14, 2019 /PRNewswire/ --Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019.
Christi Shaw, president of Lilly Bio-Medicines, will participate in a fireside chat at 1:00p.m., Eastern Time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at http://investor.lilly.com/events.cfm .
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world.

Provention Bio To Present at 8th Annual Leerink Partners Global Healthcare Conference

Retrieved on:

Wednesday, February 13, 2019

Biotechnology, Nature, Biopharmaceutical, Pharmaceutical industry, Pharmacy, Biology, Monoclonal antibodies, Teplizumab

An audio webcast will be accessible via the Events and Webcasts section of the Provention Bio website: http://investors.proventionbio.com/events .

Key Points:

An audio webcast will be accessible via the Events and Webcasts section of the Provention Bio website: http://investors.proventionbio.com/events .
Provention Bio, Inc. (Nasdaq: PRVB) is a clinical-stage biopharmaceutical company leveraging a transformational drug development strategy that is focused on the prevention or interception of immune-mediated disease.
For more information on Provention Bio, please visit www.proventionbio.com .
There area number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements.